Precision BioSciences Inc (DTIL) — Cash Flow-to-Debt Ratio
Precision BioSciences Inc (DTIL) has a Cash Flow-to-Debt Ratio of -0.18x as of March 2026, meaning its operating cash flow of $-11.94 Million could theoretically repay 0% of its total liabilities ($67.79 Million) in one year. Explore DTIL long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Precision BioSciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Precision BioSciences Inc across 10 annual periods. Also explore Precision BioSciences Inc (DTIL) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Precision BioSciences Inc (2016–2025)
Year-by-year debt coverage analysis for Precision BioSciences Inc. For market capitalisation and broader financial context, see market value of Precision BioSciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.06x | $-65.84 Million | $62.17 Million | ▼ -45.0% |
| 2024 | -0.73x | $-58.45 Million | $80.00 Million | ▼ -22.4% |
| 2023 | -0.60x | $-84.11 Million | $140.92 Million | ▼ -131.9% |
| 2022 | -0.26x | $-45.75 Million | $177.74 Million | ▼ -185.4% |
| 2021 | -0.09x | $-10.85 Million | $120.33 Million | ▲ +89.1% |
| 2020 | -0.83x | $-87.39 Million | $105.73 Million | ▼ -8.8% |
| 2019 | -0.76x | $-73.64 Million | $96.92 Million | ▼ -44.9% |
| 2018 | -0.52x | $-51.72 Million | $98.64 Million | ▼ -114.9% |
| 2017 | -0.24x | $-24.17 Million | $99.05 Million | ▼ -127.3% |
| 2016 | 0.89x | $92.27 Million | $103.16 Million | — |